Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Adès L, Borate U, Bowen D, Buckstein R, Brunner A, Carraway HE, Daver N, Díez-Campelo M, de Witte T, DeZern AE, Efficace F, Garcia-Manero G, Garcia JS, Germing U, Giagounidis A, Griffiths EA, Hasserjian RP, Hellström-Lindberg E, Iastrebner M, Komrokji R, Kulasekararaj AG, Malcovati L, Miyazaki Y, Odenike O, Santini V, Sanz G, Scheinberg P, Stauder R, van de Loosdrecht AA, Wei AH, Sekeres MA, Fenaux P.
Blood. 2023 Apr 27;141(17):2047-2061. doi: 10.1182/blood.2022018604.
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj A, Calado RT, Scheinberg P, Notaro R, Peffault de Latour R.
Front Immunol. 2019 Jun 14;10:1157. doi: 10.3389/fimmu.2019.01157. eCollection 2019.
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard.
Chandhok NS, Sekeres MA.
EClinicalMedicine. 2025 Jul 10;86:103348. doi: 10.1016/j.eclinm.2025.103348. eCollection 2025 Aug.
Diagnosis, Treatment and Prevention of Nutritional Anemia in Children: Recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics.
Chandra J, Dewan P, Kumar P, Mahajan A, Singh P, Dhingra B, Radhakrishnan N, Sharma R, Manglani M, Rawat AK, Gupta P, Gomber S, Bhat S, Gaikwad P, Elizabeth KE, Bansal D, Dubey AP, Shah N, Kini P, Trehan A, Datta K, Basavraja GV, Saxena V, Kumar RR.
Indian Pediatr. 2022 Oct 15;59(10):782-801.
Association Between Hematologic Response and Change in Health-Related Quality of Life Among Patients with Light-Chain (AL) Amyloidosis.
Rizio AA, McCausland KL, Carty MK, Conrad A, Quock TP.
Patient Relat Outcome Meas. 2023 Oct 10;14:297-304. doi: 10.2147/PROM.S421211. eCollection 2023.
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response.
Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Leung N, Gastineau DA.
Haematologica. 2007 Oct;92(10):1415-8. doi: 10.3324/haematol.11413.
Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Zhu Y, Huang J, Wang Y, Han Y, Xue S, Yang Y, Zhu Y, Cai W, Chen S.
Ann Hematol. 2024 Nov;103(11):4643-4648. doi: 10.1007/s00277-024-06027-w. Epub 2024 Oct 14.
Accuracy and Reliability of Chatbot Responses to Physician Questions.
Goodman RS, Patrinely JR, Stone CA Jr, Zimmerman E, Donald RR, Chang SS, Berkowitz ST, Finn AP, Jahangir E, Scoville EA, Reese TS, Friedman DL, Bastarache JA, van der Heijden YF, Wright JJ, Ye F, Carter N, Alexander MR, Choe JH, Chastain CA, Zic JA, Horst SN, Turker I, Agarwal R, Osmundson E, Idrees K, Kiernan CM, Padmanabhan C, Bailey CE, Schlegel CE, Chambless LB, Gibson MK, Osterman TJ, Wheless LE, Johnson DB.
JAMA Netw Open. 2023 Oct 2;6(10):e2336483. doi: 10.1001/jamanetworkopen.2023.36483.
Impact of Venetoclax Treatment Schedule on Hematologic Recovery and Treatment Response in AML Patients Unfit for Intensive Chemotherapy.
Schüpbach A, Akhoundova D, Bacher U, Nilius H, Hoffmann M, Largiadèr CR, Aebi Y, Hayoz M, Kronig MN, Pabst T.
Cancers (Basel). 2025 Mar 28;17(7):1138. doi: 10.3390/cancers17071138.
Cardiac Response Dynamics in Newly Diagnosed Light-Chain Amyloidosis Patients With Early and High-Quality Hematologic Response.
Xu CY, Guan A, Zhang L, Tian Z, Zhou DB, Shen KN, Li J.
JACC Asia. 2024 Nov 26;5(1):74-84. doi: 10.1016/j.jacasi.2024.10.005. eCollection 2025 Jan.
